Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Christopher Douville

1-50 of 107 results

View this query on the Wikidata Query Service
Detection and localization of surgically resectable cancers with a multi-analyte blood test.

scientific article published on 18 January 2018
A combination of molecular markers and clinical features improve the classification of pancreatic cysts

scientific article
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing

scientific article
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer

scientific article published on 9 December 2015
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

scientific article published in March 2018
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

scientific article published on 20 March 2018
Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs).

scientific article published on 5 February 2018
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

scientific article published on 28 April 2020
A multimodality test to guide the management of patients with a pancreatic cyst

scientific article published on 01 July 2019
Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

article
Assessing aneuploidy with repetitive element sequencing

scientific article published on 19 February 2020
Figure S6 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Supplemental Table 2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S9 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S10 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Supplemental Table 1 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S7 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Figure S3 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Supplemental Table 2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplemental Table 3 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplementary Data from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S1 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplementary Tables S1 and S2 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S1 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S6 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S8 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S8 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

supplemental table 5 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplementary Notes 1-5 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Figure 3 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Author response: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

Supplementary Figures S1-S9 from Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM

Figure S7 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Table 3 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

scientific article published on 11 August 2023
Figure S8 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Figure S4 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Supplementary Tables S1 to S6 from Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA

Figure S3 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Figure S5 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S4 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S7 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Supplementary Tables S1-S19 from Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM

Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA

Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine

identifying cancer patients from GC-patterned fragment ends of cell-free DNA

Figure S5 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S10 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Paulina is supported by:

About Paulina

Help